CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 132 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,423,350 | -26.6% | 1,439,277 | +6.9% | 0.00% | -20.0% |
| Q2 2023 | $42,790,272 | +39.5% | 1,346,029 | +7.0% | 0.01% | +25.0% |
| Q1 2023 | $30,680,677 | +80687.5% | 1,257,920 | +4.5% | 0.00% | -20.0% |
| Q4 2022 | $37,977 | -99.9% | 1,204,108 | +6.2% | 0.01% | 0.0% |
| Q3 2022 | $32,054,000 | +15.2% | 1,134,261 | +7.8% | 0.01% | +25.0% |
| Q2 2022 | $27,822,000 | -14.2% | 1,052,290 | +13.7% | 0.00% | 0.0% |
| Q1 2022 | $32,408,000 | +7.6% | 925,701 | -0.3% | 0.00% | 0.0% |
| Q4 2021 | $30,110,000 | +12.3% | 928,773 | +2.2% | 0.00% | 0.0% |
| Q3 2021 | $26,818,000 | +39.1% | 909,115 | +20.8% | 0.00% | +33.3% |
| Q2 2021 | $19,277,000 | +216.4% | 752,427 | +69.5% | 0.00% | +200.0% |
| Q1 2021 | $6,093,000 | -19.9% | 443,791 | -3.3% | 0.00% | 0.0% |
| Q4 2020 | $7,606,000 | – | 458,783 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |